Search
for
Sort by
Research 121–150 of 474
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- Towards cell-based therapy of alopecia areata: Autologous human Vδ2+ Foxp3+ γδTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- Cutaneous manifestations associated with immune checkpoint inhibitors
- What is behind the ‘swarm of bees’ in alopecia areata
- Janus kinase inhibitors for alopecia areata: A narrative review
- CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier
- Alarmin Cytokines as Central Regulators of Cutaneous Immunity
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Laser Capture Microdissection Reveals Transcriptional Abnormalities in Alopecia Areata before, during, and after Active Hair Loss
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Novel potential therapeutic targets of alopecia areata
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- The Trilogy of Skin Regeneration via Metal-Organic Frameworks Nanomedicine: Precision Management of Refractory Wounds, Pathological Scarring, and Hair Follicle Reactivation
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
- The Efficacy and Psychoneuroimmunology Mechanism of Camouflage Combined With Psychotherapy in Vitiligo Treatment
- Calreticulin: non‐endoplasmic reticulum functions in physiology and disease
- Vitiligo and alopecia areata: apples and oranges?